Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

Completed · Phase 2

Conditions studied: Leukemia, Pediatric

In brief

The purpose of this study is to determine whether Dasatinib when added to standard chemotherapy is effective and safe in the treatment of pediatric philadelphia chromosome positive acute lymphoblastic leukemia

Key facts

Study ID
NCT01460160
Run by
Bristol-Myers Squibb
People needed
106
Starts
2012-04-13
Expected to finish
2021-06-01
Last updated by the study team
2021-12-08

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.